Entourage Health to Report Fiscal Year 2023 Financial Results
Entourage Health Corp. announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.
Entourage Health Provides Corporate Update
Entourage Health Corp. Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other career opportunities, effective December 18, 2023.
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
Entourage Health Corp. announced today its financial results for the three and nine months ended September 30, 2023.
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
Entourage Health Corp. announced today it will file its third quarter 2023 financial statements and management’s discussion and analysis after-market on Monday, November 27, 2023.
Entourage Health Announces Amendment to Key Supply Agreement
Entourage Health Corp. announced it has entered into an amended supply agreement with HEXO Corp..
Entourage Health Reports Second Quarter 2023 Financial Results
Entourage Health Corp. announced today its financial results for the three months and six ended June 30, 2023.
Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis
Entourage unveils a wave of nostalgic Dime Bag® branded pre-roll offerings, now available in Ontario. Additionally, the Company introduces Syndicate-branded cannabis products, featuring exclusive limited-edition offerings from micro-cultivators now available across Ontario.
Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30
Entourage announced today it will file its second quarter 2023 financial statements and management’s discussion and analysis after market on Tuesday, August 29, 2023.
Entourage Health Announces First International Sale of Bulk Cannabis to Australia
Entourage announced today the successful sale, execution and fulfilment of its first international order of 100kg of bulk medical cannabis to Australia.
Entourage Health Announces Restructuring of Senior Secured Debt
Entourage announced today that the Company has partially repaid its senior secured credit facility with Bank of Montreal from the net proceeds of the sale of its Strathroy facility and cash.
Entourage Announces Results of 2023 Annual General Meeting of Shareholders
Entourage is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 14, 2023.
Entourage Health Reports First Quarter 2023 Financial Results
Entourage announced today its financial results for the three months ended March 31, 2023.
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
Entourage announced today its financial results for the three and nine months ended September 30, 2022.
Entourage Health Reports Second Quarter 2022 Financial Results
Entourage announced today its financial results for the three and six months ended June 30, 2022.
Entourage Health Reports Record First Quarter 2022 Financial Results
Entourage Health Corp. announced today its financial results for the three months ended March 31, 2022.
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million
Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.
Entourage Health Posts New Year 2022 Shareholder Newsletter
Entourage Health issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022.
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed Medicinal
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022
Company also confirms its certification as an Ontario Living Wage Employer, becoming one of only three cannabis cultivators with this distinction